feed,title,long_url,short_url
Benzinga,Baozun Boosts Buyback Adoption By $80M,https://benzinga.com/news/22/03/26293263/baozun-boosts-buyback-adoption-by-80m,https://bit.ly/3IIjy5g
Benzinga,"Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control",https://benzinga.com/general/biotech/22/03/26291891/novocures-ttfields-show-improved-progression-free-overall-survival-over-matched-control,https://bit.ly/37QgNSI
Benzinga,"The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO",https://benzinga.com/general/biotech/22/03/26293753/the-daily-biotech-pulse-mei-pharma-wilts-on-adverse-regulatory-development-decision-day-for-zogen,https://bit.ly/3LbYKF5
Benzinga,Volkswagen Forced To Defer EV launch Due To Ukraine War Bottleneck: Reuters,https://benzinga.com/news/22/03/26293706/volkswagen-forced-to-defer-ev-launch-due-to-ukraine-war-bottleneck-reuters,https://bit.ly/3qA1R1s
Benzinga,10 Biggest Price Target Changes For Friday,https://benzinga.com/markets/penny-stocks/22/03/26293860/10-biggest-price-target-changes-for-friday,https://bit.ly/3iybPw4
